Thank you for contacting us.
A member of our team will reply within 24 hours of your submission, during regular business hours. Our regular busines hours are 9:00am-8:00pm EST; Monday to Friday.
Topical Polls and Industry Trends
Use of Real-World Evidence in Oncology
Real-world evidence (RWE) is no longer a secondary data source, it’s becoming a core input in oncology treatment decisions. In a new survey of Canadian and U.S. oncologists, MD Analytics explores how RWE is being used in clinical practice, the scenarios where it’s most valuable, and what challenges still exist in applying it effectively.
Our latest infographic reveals where oncologists see the greatest benefit from RWE, how it supports complex decision-making, and what pharmaceutical companies can do to improve access, data quality, and clinical relevance.
The Shifting Demographics of Oncology Patients
A recent survey of oncologists in North America reveals a rising trend: more patients are being diagnosed with solid tumor cancers at a younger age. Backed by recent epidemiological studies, this shift is particularly evident in breast and colorectal cancers.
This demographic change is expected to impact treatment strategies, patient management, and how pharmaceutical companies support and communicate with younger patients. Explore the infographic to learn more about the implications for oncology care.
The Building of Stronger MSLs
Medical Science Liaisons (MSLs) play a crucial role in connecting scientific advancements with healthcare professionals. Our latest research highlights what physicians value most in MSL interactions, where key gaps exist, and which companies are leading in specific therapeutic areas.
Explore our new infographic for insights on strengthening MSL impact and delivering greater value to healthcare professionals.